Abstract
Obstet Gynecol Surv 2015;70(8):505–506 The primary site of spread and failure in most cases of advanced epithelial ovarian carcinoma (EOC) is the peritoneum. Even in relapses, the disease is typically confined to the peritoneal cavity. Previous studies have found a 20-fold higher concentration of cisplatin in the peritoneum after intraperitoneal (IP) administration compared with that in plasma after intravenous (IV) administration.